Regulatory update compiled by our experts
Articles filtered by tag
Q1 2023 Newsletter – What’s New in Clinical Development Practices & Regulations
Regulatory update compiled by our experts
Q4 2022 Newsletter – Regulations & ICH Guidelines; FDA Guidelines; Clinical Trial Data
Regulatory update compiled by our experts
Regulations & ICH Guidelines; EU/UK/US Guidance; RWD/RWE
Regulatory update compiled by our experts
COVID-19, New Regulations: Latest Industry Update
Regulatory update compiled by our experts
Clinical Trial Guidance and Legislation
Regulatory update compiled by our experts
Regulations & Guidance: Clinical Trials
Q1’s Industry Insights round up all the latest regulatory news
Clinical Trials News from around the Globe
All the latest regulatory updates compiled for you by S-cubed.
Clinical Trial Regulation, ICH E6(R2) & Brexit
Our first Industry Update of 2020 focuses on Clinical Trial Regulation, Brexit and the latest from FDA & EMA.
Finalised ICH E9(R1) Estimands and Sensitivity Analysis Guidance
We revisit Estimands after it’s adoption in November. Find out how we can help.
Global Harmonisation of Clinical Trials
Global Harmonisation of Clinical Trials is the latest focus for our quarterly roundup of the regulatory landscape with news from EMA, FDA and ICH
Protocol writing is changing – Estimands (ICH E9(R1))
This month we explain how S-cubed can assist you in applying the forthcoming regulatory guidance ICH E9(R1)